APTARGROUP INC (ATR)       115.42  -1.88 (-1.6%)

Aptar Pharma launches nasal spray pump (NYSE:ATR)

AptarGroup's (ATR) Aptar Pharma launched its first metal-free, multidose nasal spray pump APF Futurity for delivering nasal saline and other comparable over-the-counter...

Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging

Aptar Declares Quarterly Dividend and Announces 2023 Annual Meeting Details

Aptar Announces 2023 Quarterly Conference Call Dates

AptarGroup Larger Than S&P 500 Component Organon

Aptar to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023

Aptar in Top 15 of America’s Most Responsible Companies 2023 by Newsweek

AptarGroup realigns two business reporting segments (NYSE:ATR)

AptarGroup (ATR) realigns two business reporting segments, renamed reporting segments will be Aptar Closures and Aptar Beauty, effective January 1, 2023.The new segment structure...

Aptar Announces the Realignment of Two of its Business Reporting Segments

Top Buys by Directors: Trerotola's $299.5K Bet on ATR

Friday 11/4 Insider Buying Report: ATR, MRUS

Aptar Again Named a Global Top Female-Friendly Company by Forbes

Aptar Reports Third Quarter 2022 Results

Aptar and Chiesi Sign Digital Health Contract to bring Best-in-Class Disease Management Platform for Patients with Asthma and COPD

Aptar Declares Quarterly Dividend

AptarGroup is Now Oversold (ATR)

Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda

Aptar Appoints Matthew L. Trerotola to its Board of Directors

Aptar Reports Second Quarter 2022 Results

Aptar Declares Quarterly Dividend

Aptar Releases 2021 Corporate Sustainability / ESG Report

AptarGroup Larger Than S&P 500 Component Wynn Resorts

AptarGroup Enters Oversold Territory (ATR)

Aptar Named Among the 100 Best Corporate Citizens for 2022